The UK opposition Labour Party has promised that if it wins the 12 December general election it will boost health spending, abolish prescription charges, support the development of genomics and cell therapies, and ensure continued post-Brexit UK participation in EU agencies and funding programs.
But it also plans to set up a state-run generics company, use compulsory licensing provisions to secure access to cheaper medicines, and phase out R&D tax credits as well as the “Patent Box,” which lowers the tax companies pay on patent-derived profits
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?